Recordati SpA (RCDTF)
58.00
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Recordati Debt to Equity Ratio : 1.084 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.084 |
| March 31, 2026 | 1.149 |
| December 31, 2025 | 1.296 |
| September 30, 2025 | 1.299 |
| June 30, 2025 | 1.321 |
| March 31, 2025 | 1.193 |
| December 31, 2024 | 1.335 |
| September 30, 2024 | 0.8303 |
| June 30, 2024 | 0.9296 |
| March 31, 2024 | 0.9541 |
| December 31, 2023 | 1.073 |
| September 30, 2023 | 1.053 |
| June 30, 2023 | 1.159 |
| March 31, 2023 | 0.9555 |
| December 31, 2022 | 1.110 |
| September 30, 2022 | 1.056 |
| June 30, 2022 | 1.224 |
| March 31, 2022 | 1.153 |
| December 31, 2021 | 0.7181 |
| September 30, 2021 | 0.7379 |
| June 30, 2021 | 0.8641 |
| March 31, 2021 | 0.8364 |
| December 31, 2020 | 0.8316 |
| September 30, 2020 | 0.8806 |
| June 30, 2020 | 0.9299 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8788 |
| December 31, 2019 | 0.9182 |
| September 30, 2019 | 0.9524 |
| June 30, 2019 | 0.6745 |
| March 31, 2019 | 0.7013 |
| December 31, 2018 | 0.8181 |
| September 30, 2018 | 0.7046 |
| June 30, 2018 | 0.7645 |
| March 31, 2018 | 0.7234 |
| December 31, 2017 | 0.6628 |
| September 30, 2017 | 0.5874 |
| June 30, 2017 | 0.4513 |
| March 31, 2017 | 0.3388 |
| December 31, 2016 | 0.387 |
| September 30, 2016 | 0.3048 |
| June 30, 2016 | 0.3412 |
| March 31, 2016 | 0.3508 |
| December 31, 2015 | 0.3758 |
| September 30, 2015 | 0.3553 |
| June 30, 2015 | 0.3734 |
| March 31, 2015 | 0.3744 |
| December 31, 2014 | 0.4103 |
| September 30, 2014 | 0.4806 |
| June 30, 2014 | 0.4212 |
| March 31, 2014 | 0.4478 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.7166 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Avadel Pharmaceuticals Plc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 6.138B |
| Total Liabilities (Quarterly) | 3.702B |
| Shareholders Equity (Quarterly) | 2.436B |
| Current Ratio | 1.256 |
| Net Debt Paydown Yield | -0.16% |